Restriction point control of the mammalian cell cycle via the cyclin E/Cdk2:p27 complex

FEBS Journal

Volumn 277, Issue 2, 2010, Pages 357-367

  Conradie, Riaan ^a   Bruggeman, Frank J ^b   Ciliberto, Andrea ^c   Csikász Nagy, Attila ^d   Novák, Bela ^e   Westerhoff, Hans V ^b,f   Snoep, Jacky L ^a,b,f  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^d UNIVERSITY OF TRENTO   (Italy)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Cell cycle; Kinetic modeling; Metabolic control analysis; Restriction point; Systems biology

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; PROTEIN P27; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2A;

ARTICLE; CANCER CELL; CELL CYCLE; CELL CYCLE REGULATION; CELL GROWTH; CELL KINETICS; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); HUMAN; MAMMAL; MATHEMATICAL MODEL; METABOLIC REGULATION; METHODOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; SPECIES;

ANIMALS; CELL CYCLE; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P27; G1 PHASE; HUMANS; KINETICS; MODELS, BIOLOGICAL; MULTIPROTEIN COMPLEXES; NEOPLASMS;

MAMMALIA;

EID: 74549136804     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2009.07473.x     Document Type: Article

References (35)

1. Pardee A (1974) A restriction point for control of normal animal cell proliferation. Proc Natl Acad Sci USA 71, 1286 1290.
2. Planas-Silva MD, Weinberg RA (1997) The restriction point and control of cell proliferation. Current Opin Cell Biol 9, 768 772.
3. Blagosklonny MV Pardee AB (2002) The restriction point of the cell cycle. Cell Cycle 1, 103 110.
4. Yao G Lee TJ, Mori S, Nevins JR You L (2008) A bistable Rb-E2F switch underlies the restriction point. Nat Cell Biol 10, 476 482.
5. Novak B. Tyson J (2004) A model for restriction point control of the mammalian cell cycle. J Theor Biol 230, 563 579.
6. Barberis M, Klipp E, Vanoni M Alberghina L (2007) Cell size at S phase initiation: an emergent property of the G1/S network. PLoS Comput Biol 3, e64, doi :.
7. Hatzimanikatis V, Lee KH Bailey JE (1999) A mathematical description of regulation of the G1-S transition of the mammalian cell cycle. Biotechnol Bioeng 65, 631 637.
8. Aguda B Tang Y (1999) The kinetic origins of the restriction point in the mammalian cell cycle. Cell Prolifer 32, 321 335.
9. Haberichter T, Mädge B, Christopher RA, Yoshioka N, Dhiman A, Miller R, Gendelman R, Aksenov SV, Khalil IG, Dowdy SF et al. (2007) A systems biology dynamical model of mammalian G1 cell cycle progression. Mol Syst Biol 3, 84, doi :.
10. Zetterberg A Larsson O (1995) 'Cell cycle progression and growth in mammalian cells: kinetic aspects of transition events'. In Cell Cycle Control (Hutchison C Glover DM, eds), pp. 206 227. Oxford University Press, Oxford.
11. Kacser H Burns JA (1973) The control of flux. Symp Soc Exp Biol 27, 65 104.
12. Heinrich R Rapoport TA (1974) A linear steady-state treatment of enzymatic chains. General properties control, and effector strength. Eur J Biochem 42, 89 95.
13. Reijenga K, Westerhoff HV, Kholodenko BN Snoep J (2002) Control analysis for autonomously oscillating biochemical networks. Biophys J 82, 99 108.
14. Ingalls B Sauro H (2003) Sensitivity analysis of stoichiometric networks: an extension of metabolic control analysis to non-steady state trajectories. J Theor Biol 222, 23 26.
15. Kholodenko B, Demin O Westerhoff H (1997) Control analysis of periodic phenomena in biological systems. J Phys Chem B 101, 2070 2081.
16. Demin O, Westerhoff H Kholodenko B (1999) Control analysis of stationary forced oscillations. J Phys Chem B 103, 10695 10710.
17. Conradie R, Westerhoff H, Hofmeyr JH, Rohwer J Snoep J (2006) Summation theorems for flux and concentration control coefficients of dynamic systems. Syst Biol, IEE Proc 153, 314 317.
18. Snoep JL Westerhoff HV (2005) 'From isolation to integration a systems biology approach for building the Silicon Cell'. In Systems Biology: Definitions and Perspectives (Alberghina L Westerhoff HV, eds), p. 7. Springer-Verlag, Berlin/Heidelberg.
19. Maddox J (1994) Cell-cycle regulation by numbers. Nature 369, 437.
20. Hartwell LH, Hopfield JJ, Leibler S Murray AW (1999) From molecular to modular cell biology. Nature 402, C47 C52.
21. Lander ES Weinberg RA (2000) Genomics: journey to the center of biology. Science 287, 1777 1782.
22. Nurse P (2000) The incredible life and times of biological cells. Science 289, 1711 1716.
23. Gilman A Arkin AP (2002) Genetic 'code': representations and dynamical models of genetic components and networks. Annu Rev Genomics Hum Genet 3, 341 369.
24. Kumar S Feidler JC (2003) BioSPICE: a computational infrastructure for integrative biology. OMICS 7, 225.
25. Hofmeyr JH Cornish-Bowden A (1996) Co-response analysis: a new experimental strategy for metabolic control analysis. J Theor Biol 182, 371 380.
26. Skalicky DA, Kench JG, Segara D, Coleman MJ, Sutherland RL, Henshall SM, Musgrove EA Biankin AV (2006) Cyclin E expression and outcome in pancreatic ductal adenocarcinoma. Cancer Epidemiol Biomarkers Prev 15, 1941 1947.
27. Schraml P, Bucher C, Bissig H, Nocito A, Haas P, Wilber K, Seelig S, Kononen J, Mihatsch MJ, Dirnhofer S, Dirnhofer S et al. (2003) cyclin E overexpression and amplification in human tumours. J Pathol 200 (3 375 382.
28. Hayashi H, Ogawa N, Ishiwa N, Yazawa T, Inayama Y, Ito T Kitamura H (2001) High cyclin E and low p27/Kip1 expressions are potentially poor rognostic factors in lung adenocarcinoma patients. Lung Cancer 34, 59 65.
29. Tamiya T, Mizumatsu S, Ono Y, Abe T, Matsumoto K, Furuta T Ohmoto T (2001) High cyclin E/low p27Kip1 expression is associated with poor prognosis in astrocytomas. Acta Neuropathol 101, 334 340.
30. Pizzo JJD, Borkowski A, Jacobs SC Kyprianou N (1999) Loss of cell cycle regulators p27Kip1 and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival. Am J Pathol 155, 1129 1136.
31. Erlanson M, Portin C, Linderholm B, Lindh J, Roos G Landberg G (1998) Expression of cyclin E and the cyclin-dependent kinase inhibitor p27 in malignant lymphomas-prognostic implications. Blood 92, 770 777.
32. Geisen C, Karsunky H, Yucel R Moroy T (2003) Loss of p27Kip1 cooperates with cyclin E in T-cell lymphomagenesis. Oncogene 22, 1724 1729.
33. Zhou Q, He Q Liang LJ (2003) Expression of p27 cyclin E and cyclin A in hepatocellular carcinoma and its clinical significance. World J Gastroenterol 9, 2450 2454.
34. Chu IM, Hengst L Slingerland JM (2008) The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat Rev Cancer 8, 253 267.
35. Hitomi M, Yang K, Guo Y, Fretthold J, Harwalkar J Stacey DW (2006) p27Kip1 and cyclin dependent kinase 2 regulate passage through the restriction point. Cell Cycle 5, 2281 2289.